Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: NPT, AVO

Statement: American Academy of Ophthalmology and ASCRS Urge Aetna to Reverse Disruptive New Policy on Cataract Surgery


SAN FRANCISCO, July 1, 2021 /PRNewswire/ -- Aetna today is implementing a sweeping new policy that is a complete contravention of its stated commitment to build an "open health care model that will help consumers improve their health and simplify their health care experience."

Aetna, the country's third-largest provider of health insurance and services, is requiring pre-approval for all cataract surgeries starting July 1, 2021. Why has the insurer chosen to make it more difficult for each and every one of its beneficiaries to obtain this sight-restoring surgery?

The American Academy of Ophthalmology and ASCRS (American Society of Cataract and Refractive Surgery) have tried to get a clear answer, but Aetna provided no reason for creating a policy that no other large medical insurer believes necessary. The only justification Aetna has given is their own calculation that there is a less than 5 percent chance that they would deem a surgery unnecessary. Why disrupt and delay care for 95 percent of beneficiaries to address an issue that affects so few?

Here's what ophthalmologists do know: Visual impairment due to cataract is real. Cataracts reduce our patients' quality of life, interfere with their work, and puts them at increased risk for falls and car accidents.

About 4 million Americans undergo cataract surgery every year, a number that will grow as our population ages. There's almost no other surgery as effective and transformative as cataract surgery. It allows people to recover their lives. We have asked Aetna to immediately withdraw the program. They have declined to even pause it until physicians and patients can be educated on it.

Because Aetna published no updated policy documents and provided limited prior education, the new policy is already causing chaos at the doctor's office. This at a time when ophthalmology practices are struggling to fit patients in as they work through a backlog of surgeries due to COVID-19 shutdowns.

Ophthalmologists have reported that phone calls to Aetna for additional information have been met with mixed messages. Some have been told approval will be instant, while others have been told it could take up to 14 days. Some have been told to cancel all surgeries for the first two weeks of July, while others have been told there is no new policy. The policy has been implemented in such an inefficient manner that we estimate that 10,000 to 20,000 Aetna patients will have their cataract surgery unnecessarily delayed in the month of July alone. Just yesterday, a confused patient called their ophthalmologist in anger to blame him for cancelling surgery. One day before the effective date, and it's already threatening to erode trust between patients and physicians.

There must be a better way to solve this unstated issue Aetna wishes to fix; a way that helps consumers improve their health and simplify their health care experience. The nation's ophthalmologists are committed to finding a solution that does not delay or deny our patients access to vision-restoring surgery.

SOURCE American Academy of Ophthalmology


These press releases may also interest you

at 10:30
Omni Quality Living ("Omni"), a portfolio business of The Hillcore Group, a leader in long-term care and senior living, is pleased to announce effective July 2nd, 2024, it has assumed the management of five high-quality long-term care homes located...

at 10:11
The Prime Minister, Justin Trudeau, today announced the reappointment of Dr. Mona Nemer as Canada's Chief Science Advisor for a term of three years, effective September 25, 2024. A distinguished medical researcher, Dr. Nemer has served as Canada's...

at 10:10
The "TechVision50: Top 50 Advanced and Emerging Technologies" report has been added to ResearchAndMarkets.com's offering. TechVision50 is a guide of the 50 greatest opportunities in Advanced Technologies and Materials at the mid-point of 2024. This...

at 10:10
The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Viral Vector Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the viral...

at 10:05
The "The Worldwide Market for Clinical Laboratory Services, 9th Edition" report has been added to ResearchAndMarkets.com's offering. Stay ahead with insights into demographic trends, disease trends, new developments, company performance, mergers...

at 10:00
The "Drug Delivery Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Drug Delivery Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the drug...



News published on and distributed by: